Let's get this straight, though. If there was going to be some illegal activity by a generic in this situation and we hit that really hard, the commitment is there to go.... Are you suggesting...? It has been out there. The department is saying it, and they can't say where it's coming from, that investment would dry up and billions of dollars would be lost.
I want to know, if we protect those patents, if we respect those patents, if we make sure they're done properly and the drugs go to the places where they're clearly on the mark and they're identified and they're evolved, you're going to pull back investment if more people get treatments for HIV, tuberculosis, malaria? We want to protect that IP. We just want to build the work better. We want the generics and more drugs to get out there.
If that happens, are you going to pull back investment?